BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28871364)

  • 21. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome.
    Sakai Y; Horiba N; Tozawa F; Sakai K; Kuwayama A; Demura H; Suda T
    Endocr J; 1997 Oct; 44(5):687-95. PubMed ID: 9466324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome.
    Castinetti F; Morange I; Dufour H; Jaquet P; Conte-Devolx B; Girard N; Brue T
    Eur J Endocrinol; 2007 Sep; 157(3):271-7. PubMed ID: 17766708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
    Coiro V; Volpi R; Capretti L; Caffarri G; Chiodera P
    J Intern Med; 2000 Jun; 247(6):667-73. PubMed ID: 10886488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome.
    Qiao J; Li J; Zhang W; Wang C; Li J; Jiang S; Tan H; Chen Y; Liu H; Cai B; Yu Y
    Endocr J; 2021 Jul; 68(7):839-848. PubMed ID: 33790062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
    Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
    Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production.
    Howlett TA; Drury PL; Perry L; Doniach I; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):699-713. PubMed ID: 3024870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and imaging evaluation of Cushing's syndrome.
    Newell-Price J; Grossman A
    Minerva Endocrinol; 2002 Jun; 27(2):95-118. PubMed ID: 11961502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
    Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
    Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients.
    Machado MC; Valeria de Sa S; Correa-Giannella ML; Giorgi RR; Pereira MA; Cescato VA; Giannella-Neto D; Salgado LR
    Eur J Endocrinol; 2008 May; 158(5):605-13. PubMed ID: 18426818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of dexamethasone non-suppressible Cushing's disease hardly differentiated from ectopic ACTH syndrome.
    Hiramatsu R; Shimada T; Sato T
    Endocrinol Jpn; 1983 Feb; 30(1):85-91. PubMed ID: 6309506
    [No Abstract]   [Full Text] [Related]  

  • 34. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum steroid profiling in Cushing's syndrome patients.
    Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105410. PubMed ID: 31201926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Optimal Cut-off of BIPSS in Differential Diagnosis of ACTH-dependent Cushing's Syndrome: Is Stimulation Necessary?
    Chen S; Chen K; Wang S; Zhu H; Lu L; Zhang X; Tong A; Pan H; Wang R; Lu Z
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31758170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
    J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states.
    Moro M; Putignano P; Losa M; Invitti C; Maraschini C; Cavagnini F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3569-74. PubMed ID: 11061503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.